Vera Therapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | $0 | $-89.3M | $53.7M |
| FY2021 | $4.9M | $69.6M | $79.7M |
| FY2022 | $24.8M | $76.9M | $43.5M |
| FY2023 | $49.9M | $101.7M | $45.7M |
| FY2024 | $50.7M | $577.2M | $92.6M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | $0 | $-89.3M | $53.7M |
| FY2021 | $4.9M | $69.6M | $79.7M |
| FY2022 | $24.8M | $76.9M | $43.5M |
| FY2023 | $49.9M | $101.7M | $45.7M |
| FY2024 | $50.7M | $577.2M | $92.6M |